Identifying and validating subtypes within major psychiatric disorders based on frontal-posterior functional imbalance via deep learning.

Journal: Molecular psychiatry
PMID:

Abstract

Converging evidence increasingly implicates shared etiologic and pathophysiological characteristics among major psychiatric disorders (MPDs), such as schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD). Examining the neurobiology of the psychotic-affective spectrum may greatly advance biological determination of psychiatric diagnosis, which is critical for the development of more effective treatments. In this study, ensemble clustering was developed to identify subtypes within a trans-diagnostic sample of MPDs. Whole brain amplitude of low-frequency fluctuations (ALFF) was used to extract the low-dimensional features for clustering in a total of 944 participants: 581 psychiatric patients (193 with SZ, 171 with BD, and 217 with MDD) and 363 healthy controls (HC). We identified two subtypes with differentiating patterns of functional imbalance between frontal and posterior brain regions, as compared to HC: (1) Archetypal MPDs (60% of MPDs) had increased frontal and decreased posterior ALFF, and decreased cortical thickness and white matter integrity in multiple brain regions that were associated with increased polygenic risk scores and enriched risk gene expression in brain tissues; (2) Atypical MPDs (40% of MPDs) had decreased frontal and increased posterior ALFF with no associated alterations in validity measures. Medicated Archetypal MPDs had lower symptom severity than their unmedicated counterparts; whereas medicated and unmedicated Atypical MPDs had no differences in symptom scores. Our findings suggest that frontal versus posterior functional imbalance as measured by ALFF is a novel putative trans-diagnostic biomarker differentiating subtypes of MPDs that could have implications for precision medicine.

Authors

  • Miao Chang
    Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Fay Y Womer
    Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
  • Xiaohong Gong
    State Key Laboratory of Genetic Engineering and Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Xi Chen
    Department of Critical care medicine, Shenzhen Hospital, Southern Medical University, Guangdong, Shenzhen, China.
  • Lili Tang
    Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Ruiqi Feng
    Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Shuai Dong
    School of Pharmacy, Minzu University of China, Beijing 100081, China.
  • Jia Duan
    Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Yifan Chen
    Adam Smith Business School, University of Glasgow, Scotland, United Kingdom.
  • Ran Zhang
    Jiangsu Province Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu, 210009, China.
  • Yang Wang
    Department of General Surgery The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology Kunming China.
  • Sihua Ren
    Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Yi Wang
    Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Jujiao Kang
    Shanghai Center for Mathematical Science, Fudan University, Shanghai, China.
  • Zhiyang Yin
    Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Yange Wei
    Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Shengnan Wei
    Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Xiaowei Jiang
    Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Ke Xu
    Mechatronics Engineering of University of Electronic Science and Technology of China, Chengdu, 611731, China.
  • Bo Cao
    Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Yanbo Zhang
    Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Weixiong Zhang
    Department of Computer Science and Engineering, Washington University, One Brookings Drive, CampusBox 1045, St. Louis, MO, 63130, USA.
  • Yanqing Tang
    Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, China. yanqingtang@163.com.
  • Xizhe Zhang
    School of Computer Science and Engineering, Northeastern University, Shenyang, Liaoning, 110819, China.
  • Fei Wang
    Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, United States.